BRUSSELS (Reuters) – The European Commission gave approval on XXX for the use of the COVID-19 vaccine developed by U.S. company Moderna, the final step to allowing Europe to use it across the continent.
European Union countries started vaccinations on Dec. 27 and are trying to catch up with countries including the U.S. or Israel where large numbers of people have already received the inoculation.
(This story refiles to add a day of week in the first paragraph)
(Reporting by Marine Strauss @StraussMarine, editing by Kate Abnett)
